Related Experiment Video
Updated: Jun 6, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Infectious endocarditis in pediatric patients: analysis of 19 cases presenting at a medical center
Hsi-Hsien Wei1, Keh-Gong Wu, Leticia B Sy
1Department of Pediatrics, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan.
Insights
Infectious endocarditis (IE) in children is rare but serious. Staphylococcus aureus is a common cause, linked to higher mortality and embolic events in pediatric IE cases.
Area of Science:
- Pediatric infectious diseases
- Cardiology
- Microbiology
Background:
- Infectious endocarditis (IE) is a rare but potentially fatal condition in pediatric patients.
- Understanding the specific characteristics of IE in children is crucial for timely diagnosis and effective management.
Purpose of the Study:
- To review the symptoms, signs, etiology, laboratory findings, and outcomes of pediatric patients diagnosed with IE over a 10-year period.
- To identify common causative agents and associated risk factors for mortality and complications in pediatric IE.
Main Methods:
- Retrospective chart review of pediatric patients (< 18 years) diagnosed with definite IE between September 1998 and September 2008.
- Data collected included clinical presentation, microbiological etiology, laboratory results, and patient outcomes.
Main Results:
- Nineteen pediatric cases of IE were identified. Staphylococcus aureus was a frequent cause (7/19 cases).
- Fever (89.5%) and embolic events (36.8%) were common. Mortality occurred in 2 patients, with S. aureus infection associated with higher mortality.
- Elevated C-reactive protein levels were significantly higher in blood culture-positive cases (p = 0.035).
Conclusions:
- Staphylococcus aureus is a predominant etiology in pediatric IE, unlike previous reports emphasizing viridans Streptococcus.
- IE caused by S. aureus appears to carry an increased risk of mortality and embolic complications in children.
Background/Purpose:
Infectious endocarditis (IE) is a rare, but potentially fatal disease in pediatric patients. In this study, we reviewed the symptoms and signs, etiology, laboratory findings and outcomes of IE patients over the past 10 years.
Methods:
Patients (< 18 years old) with definite IE according to the modified Duke criteria, or patients with positive pathological findings, between September 1998 and September 2008 were included in the study. The etiology, symptoms and signs, laboratory findings and outcomes were collected via chart review.
Results:
Nineteen cases (13 boys and 6 girls) ranging in age from 2.5 months to 18 years (mean = 7.98 years; median = 5 years) were included. Nine out of 17 cases (52.9%) had microscopic hematuria and two out of three (66.7%) cases showed elevated rheumatoid factor levels. Seventeen (89.5%) had fever and seven (36.8%) had major vessel embolic events. Blood cultures yielded Staphylococcus aureus in seven cases, and viridans Streptococci in two cases. The other three cases had Pneumococcus, Pseudomonas aeruginosa and Candida albicans. Two patients died and one was discharged in a critical condition. Two of the seven (28.6%) patients with a positive blood culture for S. aureus died, three (42.9%) had an embolic event and one (14.3%) had central nervous system complications (intracranial hemorrhage). The initial C-reactive protein levels in the blood culture-positive group were significantly higher than those in the blood culture-negative group (p = 0.035).
Conclusion:
S. aureus is one of the most common etiologies in IE patients, while viridans Streptococcus accounts for fewer cases than suggested by previous studies. IE caused by S. aureus seems to carry a higher risk of mortality, and embolic events are associated with increased mortality.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management